Institutional Ownership
Adicet Bio Inc
CUSIP 007002108COMACETQ1 2026
13D / 13G Filings
46
Schedule 13D/13G on record
Beneficial Filers
18
Distinct reporting persons
Largest Stake
15.5%
Max % of class reported
Institutional Holders
1
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
46 filings · latest Oct 10, 2025
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Oct 10, 2025 | Orbimed Advisors LLC | 13D/A | 9.6% | — | SEC |
| 2 | May 15, 2025 | Tang Capital Management, LLC | 13G/A | 9.9% | 8.22M | SEC |
| 3 | Nov 14, 2024 | Commodore Capital LP | 13G/A | — | — | SEC |
| 4 | Nov 14, 2024 | Tang Capital Management LLC | 13G/A | 10.0% | 8.22M | SEC |
| 5 | Nov 14, 2024 | Ra Capital Management, L.P. | 13G/A | 10.0% | 8.31M | SEC |
| 6 | Nov 14, 2024 | Rtw Investments, LP | 13G/A | — | — | SEC |
| 7 | Nov 13, 2024 | Cowen Financial Products LLC | 13G/A | — | — | SEC |
| 8 | Oct 8, 2024 | Millennium Management LLC | 13G/A | 2.4% | 1.96M | SEC |
| 9 | Jul 10, 2024 | Morgan Stanley | 13G/A | 1.4% | 1.11M | SEC |
| 10 | Mar 21, 2024 | Orbimed Advisors LLC | 13D/A | 11.9% | 9.77M | SEC |
36 more beneficial-ownership filings on Premium
See the full Schedule 13D/13G history for Adicet Bio Inc.
Unlock full historyTop Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Regeneron Pharmaceuticals, Inc. | 60.5K | $412.1K |